Additional information
White powder
163222-33-1
ACI-051100
(3R,4S)- 1-(4-fluorophenyl)-3-(3S)-3-(4-fluorophenyl)-3-hydroxypropyl-4-(4-hydroxyphenyl)- 2-Azetidinone
3R,4S)- 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)- 2-Azetidinone
173.5-176.6°C
C24H21F2NO3
409.43
Ambient
2-8°C
2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-
Dyslipidemic agent





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)